Growth momentum HCD has experienced rapid leadership changes and strategic growth, including a key acquisition of Medline Industries’ DMEPOS unit and a recent CFO appointment. This suggests expanding product lines and service capabilities, presenting cross-sell opportunities across payer networks and hospital-to-home transition needs.

National reach With nationwide distribution and next-day delivery covering approximately 96 percent of the population, emphasize upsell to new geographic markets and hospitals transitioning patients to home care, targeting providers and insurers requiring broad DMEPOS coverage.

DMEPOS leadership A broad portfolio across urology, CGM and diabetes management, incontinence, ostomy, wound care, and oral nutrition positions HCD to cross-sell complementary medical supplies to existing insurer contracts and care teams managing chronic conditions.

Customer focus Maintaining a high 90 percent customer satisfaction and being recognized as a top workplace signals strong service delivery and retention potential. Leverage satisfaction metrics in renewal discussions and expand value-based partnerships with payers and providers.

Strategic talent shifts Recent additions to executive leadership in finance and people operations indicate a focus on scale, governance, and workforce optimization. This creates opportunities to propose solutions around procurement efficiency, vendor management, and HR-related patient care programs for providers.